Apotea (APOTEA) — Capital Reinvestment Ratio
Latest as of March 2026:
0.02x
Apotea (APOTEA) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (Skr112.50 Million) in capital expenditures (Skr1.70 Million). See Apotea (APOTEA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Skr112.50 Million
SEK
Capital Expenditures
Skr1.70 Million
SEK
Data as of
Mar 2026
Most recent filing
Apotea Capital Reinvestment Ratio (2022–2025)
This chart tracks Apotea's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Apotea (2022–2025)
Year-by-year Capital Reinvestment Ratio for Apotea from 2022 to 2025. For live market cap and broader valuation context, see Apotea market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | Skr333.30 Million | Skr215.60 Million | ▼ -18.6% |
| 2024 | 0.79x | Skr206.20 Million | Skr163.80 Million | ▲ +41.6% |
| 2023 | 0.56x | Skr215.80 Million | Skr121.10 Million | ▼ -87.6% |
| 2022 | 4.51x | Skr31.50 Million | Skr142.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow